Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.
Department of Pathology and Laboratory Medicine, Indiana University, IN, USA.
Shanxiang
S
Zhang
AmeriPath, Indianapolis, IN, USA.
David
D
Wilson
Department of Pathology and Laboratory Medicine, Indiana University, IN, USA.
Magdalena
M
Czader
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000473:pathology*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D015321:Gene Rearrangement; D004854:Herpesvirus 4, Human / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use; D014763:Viral Matrix Proteins / Q000276:immunology / Q000378:metabolism
C037662:EBV-associated membrane antigen, Epstein-Barr virus; C489427:MYC protein, human; D016271:Proto-Oncogene Proteins c-myc; D014763:Viral Matrix Proteins; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone